发现2-乙利索醇作为一种高强度的抗发作剂
Xianjing Zhou1, Fan Fei2, Yongxin Zhong1
1College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Journal of medicinal chemistry
|June 23, 2025
概括
研究人员优化了天然玻利,制造出一种用于治疗的强效新化合物. 这种衍生物显示出广泛的抗发作活性和改善的药物特性,提供了一个有前途的新治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 是一种神经系统疾病,以异常的神经元放电为特征.
- 天然的D-(+) - 醇具有抗发作特性,但需要优化功效和药理动力学.
研究的目的:
- 为了开发更强大的抗发作衍生物D-(+) -borneol.
- 通过化学修饰来增强药物动力学特征.
主要方法:
- 采用了优化策略:前药物修饰,生物异构和代谢部位阻断.
- 合成了各种D-(+) - 醇衍生物.
- 在体内使用PTZ (pentylenetetrazole) 和MES (最大电击) 模型评估抗发作潜力.
主要成果:
- 化合物13成为有前途的候选物,具有显著的抗发作潜力和有利的药理动力学 (114.8%的生物可用性).
- 化合物13在PTZ模型中有效延长发作延迟时间 (从285.3秒到786.5秒,服用30mg/kg口服剂量).
- 作用机制涉及降低谷氨酸质物传递的兴奋性.
结论:
- 这项研究提出了一种优化治疗中玻利衍生物的有效策略.
- 化合物13代表了一种具有广泛抗发作活性和改善药物样性质的新型化学实体,需要进一步研究临床应用.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
461
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
461
Antiepileptic Drugs: Potassium Channel Activators
289
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
289
Antiepileptic Drugs: GABAergic Pathway Potentiators
681
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
681
Epilepsy and Seizures: Overview
296
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
296
Antiepileptic Drugs: Calcium Channel Blockers
657
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
657
Antiepileptic Drugs: Sodium Channel Blockers
950
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
950


